- cafead   Oct 15, 2021 at 11:22: AM
via The U.S. Food and Drug Administration is sending Merck & Co.’s Covid-19 pill to an advisory committee for review, using a public forum to discuss any safety concerns ahead of a potential authorization.
The FDA announced the hearing for Nov. 30, saying it would weigh data on the use of the drug, molnupiravir, to treat mild-to-moderate cases in high-risk adults, confirming an earlier report by Bloomberg News. It’s the first potential therapeutic treatment for Covid-19 that the agency referred to an advisory panel, the FDA said.
article source
The FDA announced the hearing for Nov. 30, saying it would weigh data on the use of the drug, molnupiravir, to treat mild-to-moderate cases in high-risk adults, confirming an earlier report by Bloomberg News. It’s the first potential therapeutic treatment for Covid-19 that the agency referred to an advisory panel, the FDA said.
article source